Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tracer Biotechnologies
New York, New York, USAtracer.sos.colorado.gov ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Tracer Biotechnologies is a U.S.-based biotechnology company specializing in ultrasensitive detection of cancer through circulating tumor DNA (ctDNA) assays. Their proprietary platform leverages digital PCR and next-generation sequencing to provide rapid, cost-effective, and highly sensitive minimal residual disease monitoring from blood or urine samples. The technology enables decentralized MRD testing with fast turnaround times (<48 hours locally), supporting adaptive study designs in global precision oncology initiatives. The company has announced major partnerships such as with AstraZeneca to deploy its ctDNA technology for drug development trials.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic reagentsDigital polymerase chain reaction (PCR)Next-generation sequencing-based diagnosticsCirculating tumor DNA (ctDNA) assays
- Industry
- Molecular Diagnostics
02
Partnerships
AstraZeneca – multi-year agreement to use Tracer’s ctDNA technology in clinical trials for cancer drugs.
Beyond the preview
Go deeper on Tracer Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tracer Biotechnologies.